Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY

v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Total
Common Stock
Series A, Preferred Stock
Series B, Preferred Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Balance, Shares at Dec. 31, 2020   6,567,110 699,878 2,666,667    
Balance, Amount at Dec. 31, 2020 $ 17,207,557 $ 6,567 $ 699 $ 2,667 $ 146,353,232 $ (129,155,608)
Shares Issued To Consultant & Directors For Services, Shares   24,200        
Shares Issued To Consultant & Directors For Services, Amount 69,690 $ 24 0 0 69,666 0
Stock-based Compensation 60,068 0 0 0 60,068 0
Net Loss For The Three Months Ended March 31, 2021 (2,011,988) $ 0 $ 0 $ 0 0 (2,011,988)
Balance, Shares at Mar. 31, 2021   6,591,310 699,878 2,666,667    
Balance, Amount at Mar. 31, 2021 15,325,327 $ 6,591 $ 699 $ 2,667 146,482,966 (131,167,596)
Balance, Shares at Dec. 31, 2021   9,759,223        
Balance, Amount at Dec. 31, 2021 24,791,127 $ 9,759 0 0 161,772,641 (136,991,273)
Shares Issued To Consultant & Directors For Services, Shares   8,810        
Shares Issued To Consultant & Directors For Services, Amount 15,000 $ 8 0 0 14,992 0
Stock-based Compensation 264,936 0     264,936 0
Net Loss For The Three Months Ended March 31, 2021 (2,049,529) $ 0   0 0 (2,049,529)
Shares Issued - Registered Offerings - Net Of Offering Costs, Shares   820,641        
Shares Issued - Registered Offerings - Net Of Offering Costs, Amount 5,412,863 $ 822 0 $ 0 5,412,041 0
Balance, Shares at Mar. 31, 2022   10,588,674        
Balance, Amount at Mar. 31, 2022 $ 28,434,397 $ 10,589 $ 0   $ 167,464,610 $ (139,040,802)